Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
|
|
16.
|
Long-term epigenetic therapy with oral zebularine has minimal side effects and prevents intestinal tumors in mice. [electronic resource] by
- Yoo, Christine B
- Chuang, Jody C
- Byun, Hyang-Min
- Egger, Gerda
- Yang, Allen S
- Dubeau, Louis
- Long, Tiffany
- Laird, Peter W
- Marquez, Victor E
- Jones, Peter A
Producer: 20090305
In:
Cancer prevention research (Philadelphia, Pa.) vol. 1
Availability: No items available.
|
|
17.
|
Preferential response of cancer cells to zebularine. [electronic resource] by
- Cheng, Jonathan C
- Yoo, Christine B
- Weisenberger, Daniel J
- Chuang, Jody
- Wozniak, Chandra
- Liang, Gangning
- Marquez, Victor E
- Greer, Sheldon
- Orntoft, Torben F
- Thykjaer, Thomas
- Jones, Peter A
Producer: 20041019
In:
Cancer cell vol. 6
Availability: No items available.
|
|
18.
|
A pooled analysis of advanced nonsquamous non-small cell lung cancer patients with stable treated brain metastases in two phase II trials receiving bevacizumab and pemetrexed as second-line therapy. [electronic resource] by
- Gubens, Matthew A
- Chuang, Jody C
- Akerley, Wallace
- Langer, Corey J
- Clément-Duchêne, Christelle
- San Pedro-Salcedo, Melanie
- Colevas, A Dimitrios
- Dragnev, Konstantin
- Socinski, Mark A
- Wakelee, Heather A
Publication details: Journal of thoracic disease Jan 2018
In:
Journal of thoracic disease vol. 10
Availability: No items available.
|